ORAGENICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ORAGENICS, INC. (OGEN) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$3.20 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2017-08-14
- 2017-06-30: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month -$3.20M.
- 2016-06-30: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month -$2.38M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month |
|---|---|
| 2017-06-30 | -$3.20M 10-Q · filed 2017-08-14 |
| 2016-06-30 | -$2.38M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |